Dr Reddy’s to spend up to USD 300 mn on R&D in FY 2019

Read more

AstraZeneca moves US court against Aurobindo Pharma on generic

Read more

TAKE Solution announces consolidated financial results

Read more

Jubilant Life Sciences announces consolidated financial results for Q4 & 12M’FY19 Results

Read more

Dr Reddy’s Q4 PAT up 44 per cent at Rs 434 crore

Read more

Changing brand name mandatory when changing drug composition: CDSCO

Read more

Shilpa Medicare gets USFDA nod for cancer drug

Read more

Biocon and Mylan to announce the final overall survival data for Ogivri

Read more

Pfizer’s atopic dermatitis treatment meets goals in late-stage study

Read more

Scientists in new push to control cancer before curing it

Read more